Publikationsserver
Novel imantib resistance mechanisms in chronic myloid leukemia
In my research, I found that the compensatory activation of PI3K/AKT/mTor signaling pathway contributes early imatinib resistance in LAMA cell models. We also found that the auto/paracrine of GM-CSF by imatinib resistant leukemic cells confers to potent imatinib and nilotinib resistance. These findi...
Spremljeno u:
| Glavni autor: | |
|---|---|
| Daljnji autori: | |
| Format: | Dissertation |
| Jezik: | engleski |
| Izdano: |
Philipps-Universität Marburg
2007
|
| Teme: | |
| Online pristup: | PDF cijeli tekst |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
No citations were found for this record.